CRISPR Therapeutics (CRSP) – Hot Corp. News
-
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease (CRSP) (VRTX) (BLUE)
-
Vertex Pharmaceuticals (VRTX) and CRISPR Therapeutics (CRSP) Amend Collaboration for Development, Manufacturing and Commercialization of CTX001 in Sickle Cell Disease and Beta Thalassemia
-
-
-
-
-
-
-
Back to CRSP Stock Lookup